Who invested in Palvella Therapeutics?
Palvella Therapeutics's investors include Adams Street Partners, Samsara BioCapital, Blue Owl and Ligand Pharmaceuticals.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$210Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Palvella Therapeutics's investors include Adams Street Partners, Samsara BioCapital, Blue Owl and Ligand Pharmaceuticals.
Palvella Therapeutics has raised $210M across 2 rounds since 2018.
Palvella Therapeutics's most recent round was an Undisclosed round of $200M in Feb 2026.
Its most recent round, $200M in Feb 2026, is also its largest on record.
Palvella Therapeutics's first round on record, in Dec 2018, was backed by Ligand Pharmaceuticals.
Palvella Therapeutics's latest named round is an Undisclosed round, in Feb 2026.
Palvella Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.